Women's Health
FDA Office of Women's Health (OWH)
OWH protects and promotes the health of women through policy, science, education, and outreach.
Featured
![Pregnant woman_nausea](https://public4.pagefreezer.com:443/content/FDA/15-03-2024T15:32/https://www.fda.gov/files/styles/medium_3/public/Pregnant%20woman_morning%20sickness_web.jpg?itok=X_LCK0Su)
Beyond Morning Sickness: Hyperemesis Gravidarum
Hyperemesis gravidarum (HG) is the medical term for the most severe form of nausea and vomiting experienced during pregnancy. It can lead to weight loss and dehydration and may require intensive treatment.
![Women's History Month!](https://public4.pagefreezer.com:443/content/FDA/15-03-2024T15:32/https://www.fda.gov/files/styles/medium_3/public/Women%27s%20History%20Month_2.jpg?itok=7jE7WQ6y)
Women's History Month
Women’s History Month is celebrated every year in March as a time to honor women’s contributions in American History. This women’s history month, OWH reflects on 30 years of working across FDA to protect and promote women's health.
![Image of pregnant Asian woman working on a laptop](https://public4.pagefreezer.com:443/content/FDA/15-03-2024T15:32/https://www.fda.gov/files/styles/medium_3/public/Asian%20Woman_laptop_web%20resize_CROP_0.jpg?itok=N87yAxNb)
Understanding Pregnancy Exposure Registries
Are you pregnant and taking medicines or received a vaccine? You can help pregnant patients and health care providers understand the effects of medicines and vaccines used during pregnancy by volunteering to enroll in a pregnancy exposure registry study.
![HCP and Patent](https://public4.pagefreezer.com:443/content/FDA/15-03-2024T15:32/https://www.fda.gov/files/styles/medium_3/public/hcpandpatient_web.jpg?itok=IZefxuvi)
Bringing Clinical Research to Patients
This Nov. 8 webinar hosted by OWH and CDER focused on decentralized clinical trials and other novel strategies currently available for bringing clinical research to patients. CME/CNE/CPE available.
![FDA Office of Women's Health Public Workshop Menopause: Potential Impact on Clinical Pharmacology and Opportunities for Future Research](https://public4.pagefreezer.com:443/content/FDA/15-03-2024T15:32/https://www.fda.gov/files/styles/medium_3/public/FDA_OWH_Menopause_EventMaterials_WebGraphic_1600x900_v2.jpg?itok=RCQMf6uu)
Menopause: Potential Impact on Clinical Pharmacology
OWH and CDER/OCP hosted a virtual public workshop to discuss the physiologic changes that occur during menopause and the potential effects of menopause on the pharmacokinetics and pharmacodynamics of drugs.
![Women's Health Research](https://public4.pagefreezer.com:443/content/FDA/15-03-2024T15:32/https://www.fda.gov/files/styles/medium_3/public/Research_0.jpg?itok=o2suDc4y)
Women's Health Research
We promote and conduct research initiatives that advance understanding of sex differences and health conditions unique to women.
Paragraph Header
Contact Us
Office of Women's Health
10903 New Hampshire Ave WO32-2333
Silver Spring, MD 20993